ARN-25068

N/A

Report date: 2026/01/13 17:56:55

NME

Base Information

Drug NameARN-25068

Drug Alias NameARN-25068

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionDual-specificity tyrosine-phosphorylation regulated kinase 1A inhibitorsTyrosine-protein kinase FYN inhibitorsGlycogen synthase kinase-3 beta inhibitors

TargetsGlycogen synthase kinase-3 betaTyrosine-protein kinase FYNDual-specificity tyrosine-phosphorylation regulated kinase 1A

Therapy Area/IndicationsAlzheimer Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryItaly

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesUniversity Of Bologna

China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Bologna

Inactive CompaniesN/A

Active IndicationsAlzheimer Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A